Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015;15(11):1465-73.
doi: 10.1586/14737159.2015.1101348. Epub 2015 Oct 21.

Advanced technologies for the molecular diagnosis of fragile X syndrome

Flora Tassone  1   2
Affiliations
Review

Advanced technologies for the molecular diagnosis of fragile X syndrome

Flora Tassone. Expert Rev Mol Diagn. 2015.

Abstract

Fragile X syndrome (FXS), a trinucleotide repeat disorder, is the most common heritable form of cognitive impairment. Since the discovery of the FMR1 gene in 1991, great strides have been made in the field of molecular diagnosis for FXS. Cytogenetic analysis, which was the method of diagnosis in the early 1990, was replaced by Southern blot and PCR analysis albeit with some limitations. In the past few years many PCR-based methodologies, able to amplify large full mutation expanded alleles, with or without methylation, have been proposed. Reviewed here are the advantages, disadvantages and limitations of the most recent developments in the field of FXS diagnosis.

Keywords: AGG interruption; CGG repeat; FXS; Southern Blot; methylation; premutation; triplet-primed PCR.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure

The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Figures

Figure 1
Figure 1
Diagram showing the different methodologies utilized for the diagnosis of FXS. Genomic DNA (gDNA) can be isolated from whole blood, tissue, saliva or culture cells. Isolated gDNA can be amplified by PCR or digested with methylation sensitive restriction enzymes for Southern blot analysis. Conventional PCR using primers that flank the CGG repeat can amplify FMR1 alleles containing CGG repeat usually up the lower premutation range. The alleles can be visualized either on an agarose gel (a), on an acrylamide gel (b) or by capillary electrophoresis (CE) (c). CE provides accurate CGG sizing particularly if a CGG size marker is utilized. Triple primer PCR (d= premutation female; e= full mutation male) utilizes two FMR1 specific primers that flank the CGG repeat as well as a third primer that is complementary to the CGG repeat element (CGG primer). The PCR produces both full-length gene-specific FMR1 amplicons (red arrows in d) as well as triplet repeat-specific products visualized on CE as a series of peaks (d, e). Two AGG interruptions within the CGG repeat are visible, both within the normal and the premutation allele (green arrows in d) from a woman premutation carrier. Methylation status (including measure of the percent of methylation for any given allele, percent of cells carrying a methylated allele or measure of the activation ration in females) can be assessed by various mPCR strategies (g, mPCR-CE,(47); f, MM-RTPCR, modified from (69)) or by Southern blot analysis (h). Southern blot analysis (h) is performed using genomic DNA digested with the restriction enzymes EcoRI and NruI and separated on agarose gel. The DNA is transferred to a nylon membrane and then hybridized with the dig labeled specific FMR1 probe, StB12.3 (46). M= marker; C= normal control female; lane 1= full mutation female; lane 2= premutation female; lane 3= full mutation male; lane 4= mosaic male. The table in the right lower corner shows the information that can be obtained by the various PCR-methodologies. Specifically, the detection of normal, intermediate, premutation and full mutation alleles, can be obtained using any of the indicated approaches except that full mutation alleles are not amplifiable using conventional PCR. Southern blot can detect alleles from the normal throughout the full mutation range; however, sizing is obtained only for full mutation alleles.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hagerman RJ, Des-Portes V, Gasparini F, et al. Translating molecular advances in fragile X syndrome into therapy: a review. J Clin Psychiatry. 2014;75(4):e294–e307. - PubMed
    1. Bailey A, Luthert P, Dean A, et al. A clinicopathological study of autism. Brain. 1998;121(Pt 5):889–905. - PubMed
    1. Harris SW, Hessl D, Goodlin-Jones B, et al. Autism profiles of males with fragile X syndrome. American Journal of Mental Retardation. 2008;113(6):427–438. - PMC - PubMed
    1. Rogers SJ, Wehner DE, Hagerman R. The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders. J Dev Behav Pediatr. 2001;22(6):409–417. - PubMed
    1. Pieretti M, Zhang FP, Fu YH, et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 1991;66(4):817–822. - PubMed

Publication types

Substances